ImportantUpdates

Cipla achieved record revenue exceeding ₹28,000 Cr, with India business topping ₹12,500 Cr.

Cipla Limited logo
Cipla LimitedCIPLA · Filed with the exchange

Cash reserves are strong at ₹11,000 Cr.

The company is advancing complex generics, biosimilars, and new product launches, including generic Ventolin.

The Goa facility cleared inspection.

A ₹13/share dividend was declared.

Read the original filing(PDF)

No comments yet. Be the first.

More from Cipla Limited

All announcements